Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
22 mai 2023 16h51 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company” Nasdaq: LFCR), a fully integrated contract development and manufacturing organization (“CDMO”),...
Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT
22 mai 2023 16h49 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
14 avr. 2023 16h35 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., April 14, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on April 13, 2023 from the Listing...
Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business
06 avr. 2023 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., April 06, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
16 mars 2023 16h24 HE
|
Lifecore Biomedical, Inc.
Provides $10 million upfront cash commitment to Lifecore for infrastructure preparation and production capacity preparation Customer to provide reimbursement for up to $15 million in capital...
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
16 mars 2023 16h23 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
16 mars 2023 16h21 HE
|
Lifecore Biomedical, Inc.
Company Announces Intention to Explore Strategic AlternativesSigns Term Sheet with Key Customer to Materially Expand Commercial RelationshipExpands Development Pipeline from 24 to 25 Active Projects...
Lifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business
07 févr. 2023 16h30 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report
11 janv. 2023 16h35 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), announced today that it received a notice (“Notice”) on January 11, 2023 from the Listing...
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
09 janv. 2023 16h05 HE
|
Lifecore Biomedical, Inc.
$38.75 million Private Placement of Series A Convertible Preferred Stock to Support Working Capital and Capital Expenditures While Pursuing Ongoing Divestment Process of non-CDMO Assets Credit...